Serum Ischemia-Modified Albumin Levels, Myeloperoxidase Activity and Peripheral Blood Mononuclear cells in Autism Spectrum Disorder (ASD)

[1]  Y. Bozzi,et al.  Oxidative Stress and Immune System Dysfunction in Autism Spectrum Disorders , 2020, International journal of molecular sciences.

[2]  R. Kizek,et al.  Oxidative Stress in Autism Spectrum Disorder , 2020, Molecular Neurobiology.

[3]  P. Gorczyca,et al.  Autism spectrum disorder (ASD) - biomarkers of oxidative stress and methylation and transsulfuration cycle. , 2019, Psychiatria polska.

[4]  P. Crack,et al.  The influence of neuroinflammation in Autism Spectrum Disorder , 2019, Brain, Behavior, and Immunity.

[5]  S. Neşelioğlu,et al.  Ischemia-modified albumin: a unique marker of global metabolic risk in schizophrenia and mood disorders , 2018, Psychiatry and Clinical Psychopharmacology.

[6]  A. Switala,et al.  Neuroimmunologic and Neurotrophic Interactions in Autism Spectrum Disorders: Relationship to Neuroinflammation , 2018, NeuroMolecular Medicine.

[7]  A. Rahmani,et al.  Myeloperoxidase as an Active Disease Biomarker: Recent Biochemical and Pathological Perspectives , 2018, Medical sciences.

[8]  M. Ceylan,et al.  High monocyte level and low lymphocyte to monocyte ratio in autism spectrum disorders , 2017, International journal of developmental disabilities.

[9]  M. Pejović-Milovančević,et al.  Impaired Redox Control in Autism Spectrum Disorders: Could It Be the X in GxE? , 2017, Current Psychiatry Reports.

[10]  Pascual-leoneAlvaro,et al.  Abnormal Mechanisms of Plasticity and Metaplasticity in Autism Spectrum Disorders and Fragile X Syndrome. , 2016 .

[11]  E. Vasar,et al.  Antipsychotic Treatment Reduces Indices of Oxidative Stress in First-Episode Psychosis Patients , 2016, Oxidative medicine and cellular longevity.

[12]  Y. Arslan,et al.  Assessment of the role of serum ischemia-modified albumin in obstructive sleep apnea in comparison with interleukin-6 , 2016, Postgraduate medicine.

[13]  Maureen S. Durkin,et al.  Prevalence and Characteristics of Autism Spectrum Disorder Among 4-Year-Old Children in the Autism and Developmental Disabilities Monitoring Network , 2016, Journal of developmental and behavioral pediatrics : JDBP.

[14]  Christine Ecker,et al.  Neuroimaging in autism spectrum disorder: brain structure and function across the lifespan , 2015, The Lancet Neurology.

[15]  B. Dale,et al.  Link Between Increased Prevalence of Autism Spectrum Disorder Syndromes and Oxidative Stress, DNA Methylation, and Imprinting: The Impact of the Environment. , 2015, JAMA pediatrics.

[16]  S. Selek,et al.  Oxidative markers of Myeloperoxidase and Catalase and their diagnostic performance in bipolar disorder. , 2015, Journal of affective disorders.

[17]  R. Huganir,et al.  Glutamate synapses in human cognitive disorders. , 2015, Annual review of neuroscience.

[18]  A. Nagar,et al.  Corrigendum to "A quantum theory for the irreplaceable role of docosahexaenoic acid in neural cell signalling throughout evolution" Prostaglandins Leukot. Essent. Fatty Acids 88(1) (2013) 5-13 , 2014 .

[19]  M. Ceylan,et al.  Increased levels of serum neopterin in attention deficit/hyperactivity disorder (ADHD) , 2014, Journal of Neuroimmunology.

[20]  Michel Botbol,et al.  Gene × Environment Interactions in Autism Spectrum Disorders: Role of Epigenetic Mechanisms , 2014, Front. Psychiatry.

[21]  E. Eren,et al.  Ischemia-Modified Albumin: Could It Be a New Oxidative Stress Biomarker for Colorectal Carcinoma? , 2013, Gut and liver.

[22]  Janet B W Williams.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[23]  G. B. Schaefer,et al.  Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions , 2013, Genetics in Medicine.

[24]  P. Ashwood,et al.  Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment. , 2013, Neurotoxicology and teratology.

[25]  M. Ceylan,et al.  Changes in oxidative stress and cellular immunity serum markers in attention‐deficit/hyperactivity disorder , 2012, Psychiatry and clinical neurosciences.

[26]  D. Rossignol,et al.  A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures , 2011, Molecular Psychiatry.

[27]  Y. S. Kim,et al.  Prevalence of autism spectrum disorders in a total population sample. , 2011, The American journal of psychiatry.

[28]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[29]  Inbal Goshen,et al.  Immune modulation of learning, memory, neural plasticity and neurogenesis , 2011, Brain, Behavior, and Immunity.

[30]  B. Jepson,et al.  Low serum myeloperoxidase in autistic children with gastrointestinal disease , 2009, Clinical and experimental gastroenterology.

[31]  V. Vaccarino,et al.  Association of Major Depressive Disorder with Serum Myeloperoxidase and Other Markers of Inflammation: A Twin Study , 2008, Biological Psychiatry.

[32]  Barry Halliwell,et al.  Oxidative stress and neurodegeneration: where are we now? , 2006, Journal of neurochemistry.

[33]  A. Zimmerman,et al.  Neuroglial activation and neuroinflammation in the brain of patients with autism , 2005, Annals of neurology.

[34]  C. McDougle,et al.  High blood monocyte counts and neopterin levels in children with autistic disorder. , 2003, The American journal of psychiatry.

[35]  Marie-Luise Brennan,et al.  Myeloperoxidase Functions as a Major Enzymatic Catalyst for Initiation of Lipid Peroxidation at Sites of Inflammation* , 2002, The Journal of Biological Chemistry.

[36]  D. Bar-Or,et al.  A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. , 2000, The Journal of emergency medicine.

[37]  D. Guilloteau,et al.  Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. , 1994, The Journal of nutrition.

[38]  D. Priebat,et al.  Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. , 1982, The Journal of investigative dermatology.

[39]  E. Schopler,et al.  Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS) , 1980, Journal of autism and developmental disorders.

[40]  M. Cline,et al.  Monocytes, macrophages, and their diseases in man. , 1978, The Journal of investigative dermatology.

[41]  J. Melnick,et al.  Congenital rubella encephalitis. Effects on growth and early development. , 1969, American journal of diseases of children.

[42]  Luc Lecavalier,et al.  Childhood Autism Rating Scale , 2021, Encyclopedia of Autism Spectrum Disorders.

[43]  Judy Van de Water,et al.  The Role of the Immune System in Autism Spectrum Disorder , 2017, Neuropsychopharmacology.

[44]  Á. Pascual-Leone,et al.  Abnormal Mechanisms of Plasticity and Metaplasticity in Autism Spectrum Disorders and Fragile X Syndrome. , 2016, Journal of child and adolescent psychopharmacology.

[45]  M. Carter.  Diagnostic and Statistical Manual of Mental Disorders, 5th ed. , 2014 .

[46]  E. Nunez.  Preface--fatty acids and cell signalling. , 1993, Prostaglandins, leukotrienes, and essential fatty acids.

[47]  S. Chess,et al.  Autism in children with congenital rubella , 1971, Journal of autism and childhood schizophrenia.